Production (Stage)
CorMedix Inc.
CRMD
$12.36
$0.100.82%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 82.55M | 43.47M | 12.26M | 806.10K | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 82.55M | 43.47M | 12.26M | 806.10K | -- |
| Cost of Revenue | 3.97M | 3.19M | 2.01M | 1.33M | 818.50K |
| Gross Profit | 78.59M | 40.28M | 10.25M | -522.20K | -818.50K |
| SG&A Expenses | 57.81M | 58.70M | 56.70M | 51.18M | 43.24M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 68.08M | 65.83M | 63.22M | 58.95M | 54.64M |
| Operating Income | 14.47M | -22.36M | -50.96M | -58.14M | -54.64M |
| Income Before Tax | 17.18M | -19.32M | -47.54M | -54.51M | -51.63M |
| Income Tax Expenses | 0.00 | -1.39M | -1.39M | -1.39M | -1.39M |
| Earnings from Continuing Operations | 17.18 | -17.93 | -46.15 | -53.12 | -50.24 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 17.18M | -17.93M | -46.15M | -53.12M | -50.24M |
| EBIT | 14.47M | -22.36M | -50.96M | -58.14M | -54.64M |
| EBITDA | 14.92M | -22.05M | -50.77M | -58.01M | -54.57M |
| EPS Basic | 0.24 | -0.33 | -0.80 | -0.93 | -0.93 |
| Normalized Basic EPS | 0.15 | -0.22 | -0.52 | -0.59 | -0.60 |
| EPS Diluted | 0.23 | -0.33 | -0.80 | -0.93 | -0.93 |
| Normalized Diluted EPS | 0.14 | -0.22 | -0.52 | -0.59 | -0.60 |
| Average Basic Shares Outstanding | 243.20M | 235.46M | 231.34M | 229.07M | 216.82M |
| Average Diluted Shares Outstanding | 246.93M | 235.46M | 231.34M | 229.07M | 216.82M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |